In a first-of-its-kind study, researchers used an ingenious experimental setup and high-energy X-ray beams to observe a high-temperature, high-pressure chemical reaction to establish how the formation of two varied nanoscale crystalline structures in the metal cobalt is controlled.
The method enabled continuous analysis of cobalt nanoparticles as they formed from clusters that include tens of atoms to large crystals measuring 5 nm.
The study offers the proof-of-principle for a novel method to analyze the real-time formation of crystals, with prospective applications for other materials, such as oxides and alloys. The study data created “nanometric phase diagrams” that revealed the conditions controlling the structure of cobalt nanocrystals as they grew.
Published in the Journal of the American Chemical Society on November 13th, 2018, the study applied the U.S. Department of Energy-supported synchrotron X-ray beam lines at Argonne National Laboratory and Brookhaven National Laboratory. It was sponsored by the National Science Foundation.
Crystal formation in bulk cobalt prefers the hexagonal close-pack, or HCP, structure since it reduces energy to produce a stable structure. However, at the nanoscale, cobalt also tends to form the face-centered cubic, or FCC, phase, which possesses a higher energy. That can be stable because the total crystalline energy is affected by the high surface energy of tiny nanoclusters, Chen informed.
“When the clusters are small, we have more tuning effects, which is controlled by the surface energy of the OH minus group or other ligands,” he added. “We can tune the concentration of the OH minus group in the solution so we can tune the surface energy and therefore the overall energy of the cluster.”
In association with scientists from the Department of Materials Science at the University of Maryland and the two national laboratories, Chen and Xuetian Ma, a graduate research assistant, studied the polymorphic structures using experimental, theoretical, and computational modeling methods.
Image Credit: Allison Carter, Georgia Tech
News This Week
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]